Suitable matrix? [Study Per­for­mance]

posted by Ravindra  – India, 2015-07-02 10:12 (3218 d 15:38 ago) – Posting: # 15012
Views: 5,866

❝ However, Fe stimulates the production of erythrocytes in the bone marrow (hey, the site of action!) of Fe-deficient patients. In my understanding measuring in whole blood would be more reasonable.


i am wokring on this projects since last 09 years and had communication with EMEA. i personally think that USFDA guidelines is much appropriate which ask you to measure TBI (transferrin bound Iron) and TI (total iron. IN my terms if you prove both passes your product is really bio equivalent. also it is important to note that ICPMS is not the appropriate method).

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
80 visitors (0 registered, 80 guests [including 6 identified bots]).
Forum time: 01:50 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5